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cardiovascular outcomes, in patients with heart failure after an
acute myocardial infarction. Even though the average
estimated glomerular ﬁltration rate (eGFR) of these patients
was 70±21ml/min per 1.73m2, a large subset of these
patients had no established chronic kidney disease (CKD), and
data on proteinuria was not available. Only a third of the
studied patients had baseline eGFR less than 60ml/min per
1.73m2. Of interest, the subgroup of patients with eGFR
o60ml/min per 1.73m2 at baseline were not susceptible to
further renal functional deterioration. In addition, the effect of
eplerenone on renal function through different CKD stages
was not evaluated in this study. Only one patient with
worsening renal function was reported to manifest hyperka-
lemia (46mmol/l). Thus, although published after our review
was submitted, these newer results of Rossignol et al.3 are
consistent with and support the conclusions of our review.
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Urea handling in acute renal
failure
To the Editor: Bankir and Yang1 provided a very thought-
provoking account of renal physiology, linking structural and
functional details in a new and important way. Their
arguments in favor of active urea secretion in pars recta
of the proximal tubule seem particularly convincing. As
clinicians, we have been used to assessing the relative change
of concentrations of urea and creatinine to help in distingui-
shing pre-renal failure from acute tubular necrosis (ATN).
Bankir and Yang1 now state that in the case of ATN, blood
urea nitrogen (BUN) rises signiﬁcantly more than plasma
creatinine in comparison with pre-renal failure. This is not
the common interpretation. In a Nephrology Forum in the
Journal in 1998, RC Blantz discussed the pathophysiology of
pre-renal azotemia and wrote that pre-renal failure in
comparison with ATN was characterized by a high ratio of
BUN to serum creatinine.2 Dr Blantz analyzed the overall
situation in pre-renal failure as one in which glomerular
ﬁltration rate (GFR) and oxygen consumption in the
proximal tubule was reduced, citing the concept of Thurau
of ‘acute renal success’ in which the tubuloglomerular
feedback protected overworked oxygen-deprived tubules by
reducing GFR. Hence, it is entirely consistent with generalized
inhibition of active urea secretion as described in the paper by
Bankir and Yang. Also, as actual tubular necrosis is in fact a
rare ﬁnding in ‘acute tubular necrosis,’3 it is to be anticipated
that the active urea transport could be less inhibited in the
presence of ATN as compared with pre-renal failure. As
previously reported,4,5 this is in fact what has been observed: a
low fractional excretion of urea in pre-renal failure (o35%)
compared with ATN (440%).
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The Authors Reply: We are grateful to Ring1 for his
interesting comment about urea and creatinine handling in
acute renal failure. He presented more clearly than we did in
our paper,2 the description of the differences between pre-
renal failure and acute tubular necrosis (ATN). Actually, in the
normal kidney, the fractional excretion of urea (FEurea) depends
largely on a combination of inﬂuences exerted independently
on the proximal and the distal nephron. As already well known
since several decades, as shown in Figure 5 of our article,2 and
as re-emphasized by Carvounis et al.,3 a strong urea reab-
sorption occurs in the distal nephron at low urine ﬂow rates,
resulting in a dramatic fall in FEurea.
In pre-renal azotemia, FEurea may be strongly reduced
both by a decrease in proximal tubule function due to
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a reduced renal blood ﬂow, and by the low urine ﬂow that
favors passive urea reabsorption in the distal nephron. This
explains the observed predominant increase in blood urea
nitrogen compared with creatinine. In contrast, during the so-
called ATN, even if urea secretion may be impaired to some
extent as a result of proximal tubule damage, the relative
impairment in urine concentrating ability reduces passive
distal urea reabsorption and thus favors an increased urea
excretion and FEurea. A better evaluation of the contribution
of these two processes to the changes in blood urea nitrogen
and FEurea could be an interesting subject for further studies
of pre-renal failure compared with ATN, which we agree is
really a misnomer.
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